ALICIA KOBE: Open Payments
NPI 1902390313 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 42 payments from 12 companies in 2025. Trend: 2023 $49 · 2024 $0 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $266 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $26 |
| Corium, LLC | 2 | $26 |
| Tris Pharma Inc | 1 | $18 |
Products named: UBRELVY, VRAYLAR, CAPLYTA, JARDIANCE, VOQUEZNA, MOUNJARO, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across IN — which companies pay providers there.
